EACVI Premium Access

Empagliflozin ameliorates the cardiac energy-deficient state, improves cardiac function and reduces myocardial cellular volume in patients with type 2 diabetes

Topic: Epidemiology, Prognosis, Outcome

Congress Presentation

About the speaker

Doctor Sharmaine Thiru

Leeds General Infirmary, Leeds (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

3 more presentations in this session

Cost-Minimization analysis for cardiac revascularization in 12 healthcare systems based on the EuroCMR/SPINS registries

Speaker: Doctor K. Moschetti (Lausanne, CH)

Thumbnail

Large-scale, multi-vendor, multi-protocol, quality-controlled analysis of clinical cine CMR using artificial intelligence

Speaker: Doctor J. Mariscal Harana (London, GB)

Thumbnail

Long-term Prognostic Value of Cardiovascular Magnetic Resonance Imaging in Patients with Suspected Cardiac Tumor: A Multicenter Study with 4,285 Patient-years of Follow-up

Speaker: Associate Professor C. Shenoy (Minneapolis, US)

Thumbnail

Access the full session

Recent trials and breaking studies

Speakers: Doctor S. Thiru, Doctor K. Moschetti, Doctor J. Mariscal Harana, Associate Professor C. Shenoy
Thumbnail

About the event

Image

EuroCMR 2021

6 May - 8 May 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb